People - Killen Pickering Krigel

John Y. Killen, Jr., Acting Director Of NIAID's AIDS Unit Takes Over As Head Of The Division John Y. Killen, Jr., was named director of the Division of AIDS (DAIDS) at the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health in Bethesda, Md., effective April 17. He had been acting director of the division since June of last year. As the division's new chief, Killen plans to continue th

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

John Y. Killen, Jr., was named director of the Division of AIDS (DAIDS) at the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health in Bethesda, Md., effective April 17. He had been acting director of the division since June of last year.

As the division's new chief, Killen plans to continue the work he began as acting director. Among the activities he sees as having overriding importance are to "emphasize the value of basic research to the development of both treatments and vaccines" and "to improve the efficiency and effectiveness of our clinical trials network program." DAIDS currently sponsors a large number of treatment-related clinical trials nationwide, including antiretroviral strategies against the primary disease--infection with the human immunodeficiency virus (HIV)--as well as therapies for opportunistic infections that occur in people with AIDS.

A third item on Killen's agenda as DAIDS director is to promote ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Neeraja Sankaran

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio